Effect of internal mammary vessels radiation dose on outcomes of free flap breast reconstruction.
Orit Kaidar PersonMichael J EblanJoseph M CasterAmita R ShahDavid FriedLawrence B MarksClara N LeeEllen L JonesPublished in: The breast journal (2019)
To assess the impact of internal mammary (IM) vessels radiation dose on autologous free-flap based breast reconstruction outcomes. We retrospectively evaluated the medical records of breast cancer patients who underwent mastectomy and free-flap breast reconstruction after postoperative radiation therapy (RT) to the breast/chest wall with (n = 9) or without (n = 11) electively including the IM lymph nodes. Twenty patients were included. Median age at diagnosis was 50 years (range, 33-63). The median time interval between the start of RT and reconstructive surgery was 16 months (range, 6-45). The maximal IM vessels dose was not associated with the risk of all complications (P = 0.44) or fat necrosis (P = 0.31). The mean IM vessels dose was not significant for the risk of all complications (P = 0.13) but was significant for fat necrosis (P = 0.04). A high mean IM vessels dose was related to the occurrence of fat necrosis.
Keyphrases
- breast reconstruction
- adipose tissue
- radiation therapy
- lymph node
- end stage renal disease
- ejection fraction
- newly diagnosed
- minimally invasive
- fatty acid
- healthcare
- risk assessment
- patients undergoing
- risk factors
- bone marrow
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- type diabetes
- metabolic syndrome
- coronary artery disease
- acute coronary syndrome
- skeletal muscle
- body composition
- glycemic control
- weight loss
- neoadjuvant chemotherapy